On September 5, 2025, the National Administration of Medicines, Food, and Medical Technology (ANMAT) issued Provision No. 6559/2025, expanding the requirement of bioequivalence and/or bioavailability studies to oral pharmaceutical forms of hypoglycemic drugs.
This measure applies to medicinal products whose…
Minister Dias Toffoli, of the Federal Supreme Court (STF), suspended today (7) the validity of a rule that extends patents on medicines and pharmaceutical products. In a preliminary…
